115 related articles for article (PubMed ID: 796906)
1. [Non-secreting myeloma with myelomatous kidney. A case of parciall resistance to melphalen and cyclophosphamide with favorable response to nitrosourea combination].
Peña Yáñez A; Bermúdez JM; Raya J; Salmerón J; Palomo S
Rev Clin Esp; 1976 Dec; 143(6):543-50. PubMed ID: 796906
[No Abstract] [Full Text] [Related]
2. [Clinical importance of paraprotein of the type kappa and lambda in Bence-Jones myeloma].
Iavorskiĭ LI; Andreeva NE; Antipova LG; Riauzova LN
Probl Gematol Pereliv Krovi; 1979 Jun; 24(6):3-9. PubMed ID: 111238
[No Abstract] [Full Text] [Related]
3. [Therapy of malignant gammopathies].
Emmerich B
Dtsch Med Wochenschr; 1984 Jan; 109(1):26-30. PubMed ID: 6420138
[No Abstract] [Full Text] [Related]
4. [Assessment of a nitrosurea combined with cyclophosphamide and prednisone versus melphalan and prednisone in the treatment of multiple myeloma (author's transl)].
Bezares R; Bomchil G; Saslavsky J; Pavlovsky S; Curutchet M; Quiroga Micheo E; Macchi A; Musso A; Suárez A; Pizzolato M
Sangre (Barc); 1979; 24(3):241-51. PubMed ID: 472966
[No Abstract] [Full Text] [Related]
5. [Prognosis of Kahler's disease in patients treated and not treated with alkylating agents (apropos of 45 cases)].
Saporta L; Hugon C; Rondier J; Bontoux D; Delbarre F
Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):11-8. PubMed ID: 5079686
[No Abstract] [Full Text] [Related]
6. [Comparative study of the melphalan and of the cyclophosphamide in the treatment of Kahler's disease].
Bontoux D; Chenbit D; Delbarre F
Therapeutique; 1971 Jan; 47(1):27-32. PubMed ID: 5572915
[No Abstract] [Full Text] [Related]
7. [Gamma-D-paraproteinemia. Clinical case contribution based on 2 studies].
Spengler GA; Bütler R; Pflugshaupt R; Lopez V; Barandun S
Schweiz Med Wochenschr; 1967 Feb; 97(6):170-8. PubMed ID: 4175061
[No Abstract] [Full Text] [Related]
8. An overview of the status of the nitrosoureas in other tumors.
Carter SK
Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
[No Abstract] [Full Text] [Related]
9. [Visceral calcinosis induced by intravenous phosphate perfusions in myelomatous hypercalcemia].
Deshayes P; Levillain D; Cauvin M; Forthomme J
Sem Hop; 1969 Feb; 45(7):444-9. PubMed ID: 4307115
[No Abstract] [Full Text] [Related]
10. Treatment of plasma cell myeloma with cytotoxic agents.
Bergsagel DE; Pruzanski W
Arch Intern Med; 1975 Jan; 135(1):172-6. PubMed ID: 803363
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma without initial paraproteins.
Kim I; Harley JB; Weksler B
Am J Med Sci; 1972 Oct; 264(4):267-75. PubMed ID: 4630526
[No Abstract] [Full Text] [Related]
12. [Benign and malignant monoclonal hypergammaglobulinemia (gammopathy)].
Waldenström J
Schweiz Med Wochenschr; 1970 Feb; 100(7):290-6. PubMed ID: 4189916
[No Abstract] [Full Text] [Related]
13. Cyclophosphamide vs melphalan in treatment of plasma cell myeloma.
Rivers SL; Patno ME
JAMA; 1969 Feb; 207(7):1328-34. PubMed ID: 4179565
[No Abstract] [Full Text] [Related]
14. [Treatment of myeloma].
Le Chevallier PL
Sem Hop; 1971 Jan; 47(4):249-51. PubMed ID: 4322132
[No Abstract] [Full Text] [Related]
15. Sequential therapy compared with combination therapy in multiple myeloma.
Arch Intern Med; 1975 Jan; 135(1):163-71. PubMed ID: 1111465
[TBL] [Abstract][Full Text] [Related]
16. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Frei E; Schabel FM; Goldin A
Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
[No Abstract] [Full Text] [Related]
17. The chemotherapy of plasma cell myeloma and related disorders.
Coleman M; Silver RT
Antibiot Chemother (1971); 1974; 18():112-47. PubMed ID: 4219116
[No Abstract] [Full Text] [Related]
18. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.
Alexanian R; Migliore PJ
J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404
[No Abstract] [Full Text] [Related]
19. [Combination chemotherapy of multiple myeloma].
Uzuka Y; Saito Y; Ito T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1481-7. PubMed ID: 2389944
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for multiple myeloma in the dog.
Matus RE; Leifer CE; MacEwen EG; Hurvitz AI
J Am Vet Med Assoc; 1986 Jun; 188(11):1288-92. PubMed ID: 3721983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
